Fertility preservation in a young female with rectal mucinous adenocarcinoma and tailgut cyst: a multidisciplinary case report
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20253912Keywords:
Second-trimester uterine rupture, Spontaneous rupture, HemoperitoneumAbstract
Colorectal cancer (CRC) in women of reproductive age is rare, and its coexistence with congenital lesions such as tailgut cysts is exceptionally uncommon. Moreover, fertility preservation during multimodal oncologic therapy remains an evolving domain in young rectal cancer patients. We report a 22-year-old female, gravida 2 para 1, who presented with altered bowel habits. Imaging revealed an irregular rectal mass with posterior fat plane loss and a presacral cystic lesion suggestive of a tailgut cyst. Biopsy confirmed moderately differentiated mucinous adenocarcinoma of the rectum. Given the need for pelvic radiotherapy, ovarian transposition was performed to preserve fertility. The patient subsequently received 28 sessions of radiotherapy followed by six cycles of neoadjuvant CAPOX chemotherapy (capecitabine and oxaliplatin). Abdominoperineal resection was later performed, during which the presacral lesion was excised and confirmed histologically as a benign tailgut cyst. Post-treatment monitoring showed normalization of carcinoembryonic antigen (CEA) levels and no evidence of recurrence. This case highlights the importance of a multidisciplinary approach incorporating early diagnosis, fertility-preserving surgical strategies, and contemporary chemoradiation protocols. While ovarian transposition demonstrated preserved ovarian function, long-term follow-up remains crucial. The coexistence of a tailgut cyst and rectal adenocarcinoma in such a young patient raises potential embryological and oncogenic associations that merit further investigation. Fertility preservation should be an integral component of CRC management in young women. This case underscores the feasibility of successful oncologic and reproductive outcomes through personalized, multidisciplinary care.
Metrics
References
Cleveland Clinic. Rectal cancer. Cleveland Clinic; 2024. Available at: https://my.clevelandclinic.org/health/diseases/21733-rectal-cancer. Accessed on 17 May 2025.
Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global Cancer Observatory: Cancer Today. Lyon (France): International Agency for Research on Cancer; 2024. Available at: https://gco.iarc.who.int/today. Accessed on 17 May 2025.
Yee YK, Tan VPY, Chan P, Hung IFN, Pang R, Wong BCY. Epidemiology of colorectal cancer in Asia. 2009. Available at: https://pubmed.ncbi.nlm.nih.gov/20002940/. Accessed on 17 May 2025.
Pellino G, Simillis C, Kontovounisios C, Baird DL, Nikolaou S, Warren O, et al. Colorectal cancer diagnosed during pregnancy: systematic review and treatment pathways. Int J Colorectal Dis. 2017;32(3):273–81. DOI: https://doi.org/10.1097/MEG.0000000000000863
Saeed MF, Almubarak T, Khalaf S, Aslan A, Juma IM. A review of the literature, the detection and treatment of colorectal cancer during pregnancy: a case study. 2024. Available at: https://pubmed.ncbi.nlm.nih.gov/38222959/. Accessed on 17 May 2025.
Moshtaghian M, Shahsiah R, Jafari F, Aghili M. Malignant transformation of tailgut cyst to squamous cell carcinoma, a rare case with poor outcome. Clin Case Rep. 2023;11:e6893. DOI: https://doi.org/10.1002/ccr3.6893
Huber D, Simonson C, Fournier I, Dischl-Antonioni I, Pena Rios FJ, Francey I, et al. Utero-ovarian transposition before pelvic radiation in a patient with rectal cancer: a case report and systemic literature review. Front Surg. 2024;11:1336047. DOI: https://doi.org/10.3389/fsurg.2024.1336047
Lambertini M, Peccatori FA, Demeestere I, Amant F, Wyns C, Stukenborg JB, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2020;31(12):1664-78. DOI: https://doi.org/10.1016/j.annonc.2020.09.006
Shylasree TS, Kazi M, Saklani A. Ovarian transposition in young women with locally advanced rectal cancer – is there evidence for harm? Colorectal Dis. 2022;24(10):1249–50. DOI: https://doi.org/10.1111/codi.16280
Conroy T, Bosset JF, Etienne PL, Rio E, François É, Mesgouez-Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702–15. DOI: https://doi.org/10.1016/S1470-2045(21)00079-6
Petrelli F, Trevisan F, Cabiddu M, Sgroi G, Bruschieri L, Rausa E, et al. Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes. Ann Surg. 2020;271(3):440–8. DOI: https://doi.org/10.1097/SLA.0000000000003471
McShane JN, Armstrong DE. Retrospective analysis of the safety of FOLFOX compared to CAPOX for adjuvant treatment of stage III colorectal cancer in Newfoundland patients. Gastrointest Disord. 2022;4(3):214–22. DOI: https://doi.org/10.3390/gidisord4030020
Willis MA, Enderes J, Exner D, Stoffels B, Tischler V, Luetkens J, et al. Zufallsbefund eines intestinal differenzierten Adenokarzinoms in einer Tailgut Zyste nach robotisch-assistierter Resektion [Incidental finding of an intestinally differentiated adenocarcinoma in a tailgut cyst after robotic-assisted resection]. Z Gastroenterol. 2021;59(7):677–82. DOI: https://doi.org/10.1055/a-1330-9194
Wang YS, Guo QY, Zheng FH, Huang ZW, Yan JL, Fan FX, et al. Retrorectal mucinous adenocarcinoma arising from a tailgut cyst: a case report and review of literature. World J Gastrointest Surg. 2022;14(9):1072–81. DOI: https://doi.org/10.4240/wjgs.v14.i9.1072
American Cancer Society. Key statistics for colorectal cancer. Atlanta: American Cancer Society; 2024. Available at: https://www.cancer.org/cancer/types/colon-rectal-cancer. Accessed on 17 May 2025.